| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/14/2004 | CN1134260C Method of treatment for lung diseases using antisense oligonucleotides |
| 01/14/2004 | CN1134259C Utilization of derivatives of tetrahydropyridines (or 4-hydroxypiperdines)-butylazols in preparation of a medicament for the treatment of pain |
| 01/14/2004 | CN1134258C Polymer coated tablet comprising amoxycillin and clavulanate |
| 01/14/2004 | CN1134257C Treatment agent |
| 01/14/2004 | CN1134256C Application of substituted aminomethyl chromans in order to prevent neural degeneration and to promote neural regeneration. |
| 01/14/2004 | CN1134255C Antineoplastic cocoa extracts, method for making and uses |
| 01/14/2004 | CN1134254C Transdermal therapeutic system (TTS) contg. oxybutynin |
| 01/14/2004 | CN1134253C Oral slow-releasing opioid formulations and method for preparing the same |
| 01/13/2004 | USRE38386 Retardation of metalloproteinase incidental to HIV and/or AIDS |
| 01/13/2004 | US6677492 Sevoflurane |
| 01/13/2004 | US6677488 Substituted biphenyl compounds for the treatment of inflammation |
| 01/13/2004 | US6677470 Novel compositions of conjugated linoleic acids; human and animal nutrition |
| 01/13/2004 | US6677462 S-(+)-4-methoxy-6-phenethyl-5,6-dihydro-pyran-2-one; plant extracts for nutraceutical foods, topical ointments |
| 01/13/2004 | US6677456 As antitumor compound; can be orally administered |
| 01/13/2004 | US6677455 Potassium salt of S-omeprazole |
| 01/13/2004 | US6677453 Production of polymorphic forms I and II of finasteride by complexation with group I or II metal salts |
| 01/13/2004 | US6677450 N12, n13-bridged sugar derivatives of indolylopyrrolocarbazoles, useful in inhibiting the proliferation of tumor cells |
| 01/13/2004 | US6677435 Includes an active therapeutic agent joined to a blocking moiety sensitive to the catalytic action of molecules having retro- aldol and retro-michael catalytic activity; antitumor; anticarcinogenic agents |
| 01/13/2004 | US6677383 Hydroxylation activated prodrugs |
| 01/13/2004 | US6677381 Guaifenesin tannate |
| 01/13/2004 | US6677378 Monoamine reuptake inhibitors for treatment of CNS disorders |
| 01/13/2004 | US6677377 Structure based discovery of inhibitors of matriptase for the treatment of cancer and other conditions |
| 01/13/2004 | US6677376 Complexes comprising rotamase inhibitors and cyclophilins, administered for prevention of neurodegenarative diseases such as parkinson's or alzheimer's disease |
| 01/13/2004 | US6677374 Nervous system disorders |
| 01/13/2004 | US6677373 Polymorphic B form of 3-(cyclopropylmethoxy)-4-[4-(methylsulfonyl)phenyl]-5,5-dimethyl-5H-furan-2-one |
| 01/13/2004 | US6677372 N-(3-benzofuranyl)urea-derivatives |
| 01/13/2004 | US6677370 Stabilizing microtubules and preventing depolymerization; antiproliferative, anticarcinogenic and antiinflammatory agents; autoimmune diseases |
| 01/13/2004 | US6677369 Antithrombotic agents |
| 01/13/2004 | US6677368 4-aryl substituted indolinones |
| 01/13/2004 | US6677365 Antagonists of MCP-1 function and methods of use thereof |
| 01/13/2004 | US6677364 Substituted sulfonylphenylheterocycles as cyclooxygenase-2 and 5-lipoxygenase inhibitors |
| 01/13/2004 | US6677363 Administering pioglitazone or salt, oxime insulin sensitizer, fk-614, krp-297, and 5-((6-(2-fluorobenzyloxy)-2-naphthyl)methyl)-2,4-thiazolidinedione to treat diabetes |
| 01/13/2004 | US6677361 Topical formulations for the transdermal delivery of niacin and methods of treating hyperlipidemia |
| 01/13/2004 | US6677359 N-substituted glycine derivatives |
| 01/13/2004 | US6677358 NIDDM regimen |
| 01/13/2004 | US6677357 Nerve growth factor; animal growth regulator; antitmor agent |
| 01/13/2004 | US6677356 Concurrently administering pyridoxal-5'-phosphate, pyridoxamine, pyridoxal, or a 3-acylated pyridoxal analogue with angiotensin converting enzyme inhibitor,calcium channel blocker, adrenergic blocking agent, vasodilator or diuretic |
| 01/13/2004 | US6677355 Hydroxamic acid compounds useful as matrix metalloproteinase inhibitors |
| 01/13/2004 | US6677354 Treating sleep, brain, sexual, cardiovascular, nervous system, psychological, glandular, and gastrointestinal disorders |
| 01/13/2004 | US6677352 Non-insulin dependent, latent autoimmune, gestational diabetes treatment; impaired glucose tolerance; obesity, hypotensive agents |
| 01/13/2004 | US6677351 Useful in treatment of asthma and inflammation |
| 01/13/2004 | US6677350 Administering chalcone-like vinylcarbonyl compounds to prevent or treat mycobacterium infections/tuberculosis |
| 01/13/2004 | US6677349 Sulfonamide and sulfamide substituted imidazoquinolines |
| 01/13/2004 | US6677346 Methods comprising intranasal morphine |
| 01/13/2004 | US6677345 Cyclin dependent kinase inhibitors |
| 01/13/2004 | US6677344 Chymase inhibitor for the treatment of eosinophilia |
| 01/13/2004 | US6677342 Partial fatty acid oxidation inhibitors in the treatment of congestive heart failure |
| 01/13/2004 | US6677340 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 01/13/2004 | US6677339 S-3-(4-(3,5-dichloropyrid-4-ylcarboxamido)phenyl)-2-(4,6-dimet hoxy-1,3,5-triazin-2-ylamino)propanoic acid for example; inhibit binding of alpha 4 integrins to their ligands, for treating immune or inflammatory disorders |
| 01/13/2004 | US6677338 Serotonin transport inhibitors |
| 01/13/2004 | US6677337 1,2-dihydropyrazol-3-ones which controls inflammatory cytokines |
| 01/13/2004 | US6677335 Pharmaceutically active compounds |
| 01/13/2004 | US6677334 Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof |
| 01/13/2004 | US6677333 2H-phthalazin-1-one derivatives and drug containing its derivatives as active ingredient |
| 01/13/2004 | US6677332 Amide-substituted piperidine or azepine derivatives to treat drug abuse and tinnitus |
| 01/13/2004 | US6677329 Non-aromatic estrogenic steroids with a hydrocarbon substituent in position 11 |
| 01/13/2004 | US6677328 Administering ursodiol to prevent cancer |
| 01/13/2004 | US6677327 Food comprising water soluble protein and lecithin; oil-free |
| 01/13/2004 | US6677326 Corticosteroid formulation comprising less than 2.5 mg prednisolone for once daily administration |
| 01/13/2004 | US6677325 Steroid sulphatase inhibitors |
| 01/13/2004 | US6677324 Mixture includes 7a-(e-aminoalkyl)-estratriene; hormone replacement therapy; menopause |
| 01/13/2004 | US6677323 Administering aerosol particles of mometasone furoate in the form of dry powders, solutions, or aqueous suspension to treat allergic rhinitis and asthma |
| 01/13/2004 | US6677322 Administering in the form of aerosolized particles, to treat lungs while minimizing systemic bioavailability; treating corticosteroid-responsive diseases such as asthma |
| 01/13/2004 | US6677321 Methods and compositions for treatment of inflammatory disease |
| 01/13/2004 | US6677320 Mixture with chelate compound; bone disorders |
| 01/13/2004 | US6677319 Phosphatidylcholine as medication with protective effect large intestinal mucosa |
| 01/13/2004 | US6677318 Cross-linked agent for generation of a long-lasting satiety effect and method for the production of the said |
| 01/13/2004 | US6677317 Disaccharide derivatives for treating hyperglycaemia |
| 01/13/2004 | US6677316 Adenosine derivatives and methods of administration |
| 01/13/2004 | US6677311 Inducible HSV-TK in transformed cell populations |
| 01/13/2004 | US6677310 Ring-expanded nucleosides and nucleotides |
| 01/13/2004 | US6677309 Anthracycline derivatives |
| 01/13/2004 | US6677308 Integrin antagonists; antitumor, antimetastasis, anticarcinogenic agents; angiogenesis and restenosis inhibitors; osteoporosis |
| 01/13/2004 | US6677305 Insulin-like growth factor agonist molecules |
| 01/13/2004 | US6677304 Ophthalmic formulations |
| 01/13/2004 | US6677302 Compositions and methods for the treatment of viral disorders |
| 01/13/2004 | US6677298 Protein antagonist; antidiabetic agents, antilipemic agents |
| 01/13/2004 | US6677153 Antisense antibacterial method and composition |
| 01/13/2004 | US6677145 Isolating a nucleotide sequence having specific sequence, constructing a vector consists of an isolated nucleotide sequence operably linked to a promoter, introducing the vector into host cell for expression of elongase enzyme |
| 01/13/2004 | US6677133 Methods of reducing microbial resistance to drugs |
| 01/13/2004 | US6676979 Laxative; anticholesterol agents |
| 01/13/2004 | US6676977 Pharmaceutical compositions and methods for reducing the appearance of cellulite |
| 01/13/2004 | US6676973 Method of treating ovarian cancers with cadmium |
| 01/13/2004 | US6676971 Crosslinked macromolecules |
| 01/13/2004 | US6676970 Subcutaneous osteoporosis compositions |
| 01/13/2004 | US6676967 Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia |
| 01/13/2004 | US6676966 Encased in polymeric film soluble at neutral to alkaline ph |
| 01/13/2004 | US6676965 Enteric coated formulation for bisphosphonic acids and salts thereof |
| 01/13/2004 | US6676962 Patch having elastic backing layer inert to active substance and self adhesive matrix of drug, metal crosslinked poly-acrylate adhesive and fatty acid |
| 01/13/2004 | US6676959 Nicotine-containing pharmaceutical compositions giving a rapid transmucosal absorption |
| 01/13/2004 | US6676957 Non-absorbent substrates for the inhibition of exoprotein production from gram positive bacteria |
| 01/13/2004 | US6676956 Oil-in-water emulsion for protecting human organs against peroxidation |
| 01/13/2004 | US6676950 Administration of at least one antagonist specific for the neurokinin receptor family for inhibiting hiv infection in a patient |
| 01/13/2004 | US6676934 Antitumor agents; prevent or suppress glucose uptake; disrupt microtubules; induce apoptosis |
| 01/13/2004 | US6676933 Synergistic mixtures; gastrointestinal disorders |
| 01/13/2004 | US6676932 Ultraviolet absorbent, photostabilizer, ultraviolet ray-absorbing composition, photostabilized composition and external preparation for skin |
| 01/13/2004 | US6676931 Buccal, polar and non-polar spray or capsule |
| 01/13/2004 | US6676930 Administering dose of mixture of lipid crystals comprising surfactant and spreading agnet as aerosol through an external airway of a mammal for enhancing mammalian eustachian tube lumen patency and pressure equalization performance |
| 01/13/2004 | US6676909 Method for recovery of metals from metal-containing materials using medium temperature pressure leaching |
| 01/13/2004 | US6676855 Ethyl nitrite; maintaining circulation to abdominal organs |